Stock listing

NASDAQ:CAPR Capricor Therapeutics, Inc. Stock

Home listing (NASDAQ) of Capricor Therapeutics, Inc.

Follow Capricor Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:CAPR

$6.71 USD -0.56 (-7.7%)

Close on Oct 16, 2026

Since Jul 6, 2026 -70.1% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
$6.68 – $7.25 USDOct 16, 2026
Volume
1.92M sharesOct 16, 2026
Market value
$390.1M USDAt the close on Oct 16, 2026 · price × 58.14M shares outstanding
Capricor Therapeutics, Inc. logo
Ticker
NASDAQ:CAPR
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Capricor Therapeutics (NASDAQ:CAPR) Q2 2026 Earnings Call

    Thu, Aug 13, 2026 · 4:30 PM ET

    Watch Transcript

  • Capricor Therapeutics (NASDAQ:CAPR) Q1 2026 Earnings Call

    Tue, May 12, 2026 · 4:30 PM ET

    Watch Transcript

  • Capricor Therapeutics (NASDAQ:CAPR) Q4 2025 Earnings Call

    Thu, Mar 12, 2026 · 4:30 PM ET

    Watch Transcript

Latest news

Capricor Therapeutics Presents Positive HOPE-3 Open-Label Extension Data on Upper Limb Function in Duchenne Muscular Dystrophy at 2026 World Muscle Society Congress

Oct 5, 2026

Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress

Sep 17, 2026

SHAREHOLDER REMINDER: Berger Montague Reminds Capricor Therapeutics, Inc. (CAPR) Investors of the September 28, 2026 Deadline

Sep 11, 2026

Issued by another party

Pomerantz LLP Issues Reminder to Investors in Capricor Therapeutics, Inc. of Class Action Filing - CAPR

Aug 27, 2026

Issued by another party

Capricor Therapeutics, Inc. (CAPR) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before September 28, 2026 Lead Plaintiff Deadline

Aug 25, 2026

Issued by another party

Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA

Aug 24, 2026

Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR

Aug 21, 2026

Pomerantz LLP Alerts Shareholders to Investor Suit Against Capricor Therapeutics, Inc. - CAPR

Aug 17, 2026

Issued by another party

Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Aug 13, 2026

Capricor Therapeutics, Inc. (CAPR) Securities Fraud Investigation - Levi & Korsinsky

Aug 3, 2026

Issued by another party

All Capricor Therapeutics, Inc. news

Decks

Capricor Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
37 in the last 12 months · 185 in all · newest Oct 5, 2026 · oldest 2019
Calls
24 calls with a replay · 24 with a transcript · latest Aug 13, 2026
Decks
34 decks · latest August 2026

Where Capricor Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:CAPR · Home listing · This pageNASDAQUnited StatesUSD
gettex:4LN2gettexGermanyEUR
Tradegate:4LN2TradegateGermanyEUR
LS Exchange:A2PLU4LS ExchangeGermanyEUR
Lang & Schwarz:A2PLU4Lang & SchwarzGermanyEUR
BOATS:CAPRBOATSUnited StatesUSD
Dusseldorf:4LN2DusseldorfGermanyEUR
Frankfurt:4LN2FrankfurtGermanyEUR
Stuttgart:4LN2StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Capricor Therapeutics, Inc.